Powered by Advanced and Clinically Tested Bioprinting Technologies
PrintBio Hernia, in collaboration with leading surgeons, is pioneering advanced 3D printing technologies to deliver innovative surgical solutions. This vision comes to life in DynaFlex™ Programmable Surgical Mesh (PSM) — an FDA 510(k)-cleared 3D-printed bioresorbable surgical mesh, and the first of its kind in the category. DynaFlex™ PSM is designed to be infinitely customizable across multiple clinically relevant scenarios that provide control to adjust flex and stabilize in any vector, direction or zone within the hernia mesh using MetaDirectional Flex™ technology. Unlike category-standard knitted or woven mesh, DynaFlex™ PSM has no cross-filament “knots, weaves or loops”, that can harbor bacteria or interstitial spaces that easily deform under minimal strain, that can disrupt tissue integration.
Our Products
PrintBio has developed unique capabilities, materials and technologies that enabled the creation of the first ever living tissue implants implanted in patients.
Leveraging this material science, regulatory and clinical experience, PrintBio is launching its first product that provides physicians with unprecedented capabilities in managing their patients, 3DMatrix DynaFlex™, our next generation product adds PrintBio’s proprietary MetaDirectional Flex™ capabilities to its first ever 3D-printed bioresorbable surgical mesh.
Investor Relations
Corporate Profile
PrintBio is a clinical- and commercial-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting and material science technologies to deliver safe, functional and personalized products, and living tissues and organs, engineered and produced on-demand for patients.
